Ian Dixon

Director/Board Member at NYRADA INC.

Net worth: 4 M $ as of 31/05/2026

Health Technology

Consumer Services

Technology Services

Profile

Ian Dixon was the founder of Genscreen Pty Ltd. founded in 2002, Cynata, Inc. founded in 2011, Exopharm Ltd. founded in 2013 where Dr. Dixon was Chief Executive Officer, Director & MD from 2013 to 2024, and Cardio Therapeutics Pty Ltd. founded in 2014.
Dr. Dixon is currently Managing Director at Altnia Holdings Pty Ltd., Independent Non-Executive Director at Nyrada, Inc. since 2020, and a Member of the Australia Institute of Co. Directors.
Former positions include Executive Director at Medigard Ltd., Director-Product Group at Vision Systems Pty Ltd., Non-Executive Director at Cell Therapies Pty Ltd., Non-Executive Director at Noxopharm Ltd. from 2016 to 2020, and Owner at Cynata Therapeutics Ltd. Education includes a doctorate from Monash University and undergraduate and MBAistration degrees from Swinburne University of Technology.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NYRADA, INC. 8.94%	20/02/2026	9,780,699 ( 8.94% )	4 M $	31/05/2026

Ian Dixon active positions

Companies	Position	Start
NYRADA INC.	Director/Board Member	01/09/2020
Altnia Holdings Pty Ltd. Altnia Holdings Pty Ltd. Investment ManagersFinance Provides investment services	Corporate Officer/Principal	-
Australia Institute of Co. Directors	Corporate Officer/Principal	-

All active positions of Ian Dixon

Former positions of Ian Dixon

Companies	Position	End
EXOPHARM	Founder	01/05/2024
NOXOPHARM LIMITED	Director/Board Member	31/08/2020
Genscreen Pty Ltd.	Founder	01/01/2018
CYNATA THERAPEUTICS LIMITED	Corporate Officer/Principal	-
Cardio Therapeutics Pty Ltd. Cardio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Founder	-

See the detail of Ian Dixon's experience

Training of Ian Dixon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ian Dixon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Medigard Ltd. Medigard Ltd. Packaged SoftwareTechnology Services Engages in the development of innovative medical technologies	Technology Services
Vision Systems Pty Ltd. Vision Systems Pty Ltd. Medical SpecialtiesHealth Technology Develops, manufactures, & distributes technology products and services to healthcare markets	Health Technology
Monash University Monash University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Swinburne University of Technology Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cynata Therapeutics Ltd. Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services	Health Technology
Cell Therapies Pty Ltd.
Australia Institute of Co. Directors
Cynata, Inc. Cynata, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in stem cell research and development services	Commercial Services
Genscreen Pty Ltd.
Noxopharm Ltd. Noxopharm Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment	Health Technology
Altnia Holdings Pty Ltd. Altnia Holdings Pty Ltd. Investment ManagersFinance Provides investment services	Finance
Cardio Therapeutics Pty Ltd. Cardio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Nyrada, Inc. Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs	Health Technology
Exopharm Ltd. Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent	Health Technology